Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Graul Regina Margaret Insider Profile
4 Followers
Graul Regina Margaret, President & CEO, Director at Cyclerion Therapeutics, holds 100.30K shares in Cyclerion Therapeutics (Ticker: CYCN).
Graul Regina Margaret has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Graul Regina Margaret's holdings
Insider Roles
President & CEO, Director
Roles that Graul Regina Margaret holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Graul Regina Margaret
Graul Regina Margaret's Trading History
List of latest transactions for each holding click on a transaction to see Graul Regina Margaret's performance on stock
You May Also Like
Graul Regina Margaret insider profile FAQ
What is the percentage of profitable transactions made by Graul Regina Margaret?
The percentage of profitable transactions made by Graul Regina Margaret is ―.
What is the average return per transaction made by Graul Regina Margaret?
The average return per transaction made by Graul Regina Margaret is ―.
What stocks does Graul Regina Margaret hold?
Graul Regina Margaret holds: CYCN stocks.
What was Graul Regina Margaret’s latest transaction?
Graul Regina Margaret latest transaction was an Uninformative Buy of ―.
What was Graul Regina Margaret's most profitable transaction?
Graul Regina Margaret’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Graul Regina Margaret's role in Cyclerion Therapeutics?
Graul Regina Margaret's role in Cyclerion Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.